They showed that the RASSF6 methylation status was significantly assoctiated with a poor prognosis and a shorter overall survival in patients with pre-B-ALL which suggested the epigenetic regulation of RASSF6 during ALL progression [76]. Here, RASSF6 is linked to acute lymphoblastic leukemia.